Literature DB >> 19093787

Reversing cancer from inside and out: oncogene addiction, cellular senescence, and the angiogenic switch.

Dean W Felsher1.   

Abstract

Cancer is largely caused by genetic events that result in the mutation of oncogenes or tumor suppressor genes, leading to cell autonomous proliferation and growth. The repair of these mutant gene products may be expected to subvert this neoplastic behavior. Indeed, oncogene inactivation can result in the elimination of all or almost all tumor cells by various mechanisms through the phenomena described as oncogene addiction. Recently, we have shown that oncogene addiction occurs through at least two broad classes of mechanisms: tumor cell intrinsic mechanisms of cellular senescence and apoptosis; and tumor cell extrinsic host-dependent mechanisms that include the shut-down of angiogenesis. We have argued that the abatement of oncogenic activity within a cancer cell not only leads to the demise of a tumor from within but also through the instruction of the restoration of the microenvironment.

Entities:  

Mesh:

Year:  2008        PMID: 19093787     DOI: 10.1089/lrb.2008.63403

Source DB:  PubMed          Journal:  Lymphat Res Biol        ISSN: 1539-6851            Impact factor:   2.589


  12 in total

1.  Survivin inhibition by an interacting recombinant peptide, derived from the human ferritin heavy chain, impedes tumor cell growth.

Authors:  Astrid Weiss; Boris Brill; Corina Borghouts; Natalia Delis; Laura Mack; Bernd Groner
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-18       Impact factor: 4.553

Review 2.  An essential role for the immune system in the mechanism of tumor regression following targeted oncogene inactivation.

Authors:  Stephanie C Casey; Yulin Li; Dean W Felsher
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

Review 3.  The MYC oncogene is a global regulator of the immune response.

Authors:  Stephanie C Casey; Virginie Baylot; Dean W Felsher
Journal:  Blood       Date:  2018-03-07       Impact factor: 22.113

4.  Tumor dormancy, oncogene addiction, cellular senescence, and self-renewal programs.

Authors:  David I Bellovin; Bikul Das; Dean W Felsher
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

5.  Trefoil factor 1 acts to suppress senescence induced by oncogene activation during the cellular transformation process.

Authors:  Daniel R Radiloff; Timothy P Wakeman; Junjie Feng; Stephen Schilling; Edward Seto; Xiao-Fan Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-30       Impact factor: 11.205

6.  Systems biology of tumor dormancy: linking biology and mathematics on multiple scales to improve cancer therapy.

Authors:  Heiko Enderling; Philip Hahnfeldt; Lynn Hlatky; Nava Almog
Journal:  Cancer Res       Date:  2012-03-13       Impact factor: 12.701

7.  Impact of hydrodynamic injection and phiC31 integrase on tumor latency in a mouse model of MYC-induced hepatocellular carcinoma.

Authors:  Lauren E Woodard; Annahita Keravala; W Edward Jung; Orly L Wapinski; Qiwei Yang; Dean W Felsher; Michele P Calos
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

Review 8.  Noncanonical roles of the immune system in eliciting oncogene addiction.

Authors:  Stephanie C Casey; David I Bellovin; Dean W Felsher
Journal:  Curr Opin Immunol       Date:  2013-04-06       Impact factor: 7.486

9.  Concomitant targeting of EGF receptor, TGF-beta and SRC points to a novel therapeutic approach in pancreatic cancer.

Authors:  Sophie Deharvengt; Melina Marmarelis; Murray Korc
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

10.  The Culture-Repopulating Ability assays and incubation in low oxygen: a simple way to test drugs on leukaemia stem or progenitor cells.

Authors:  Maria Grazia Cipolleschi; Elisabetta Rovida; Persio Dello Sbarba
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.